Literature DB >> 11897575

Malaria parasites giving rise to recrudescence in vitro.

Shusuke Nakazawa1, Takashi Maoka, Haruki Uemura, Yoshihiro Ito, Hiroji Kanbara.   

Abstract

Recrudescences were simulated in vitro with drug treatment to examine how drug-sensitive parasites survive the treatment. Various numbers of cultured parasites were treated with lethal doses of pyrimethamine or mefloquine for various lengths of time. Recrudescences were observed in parasite populations with larger initial numbers of parasites when the treatment duration was prolonged. Equal numbers of parasitized erythrocytes were treated with various concentrations of pyrimethamine or mefloquine. There was no clear linear relationship between the incidence of recrudescence and the drug concentration. Parasites that had recrudesced were continuously allowed to recrudesce in the succeeding recrudescence experiments. Both the duration from the cessation of treatment to the time at which the recrudescent parasitemia level reached 1% and the growth rate of recrudescent parasites were equal among these recrudescences. The recrudescent parasites in these experiments were as sensitive to the drugs as the parasites tested before treatment were. These results suggest that a parasite culture may contain parasites in some phases that are not killed by drug for up to 10 days, which explains the recrudescences that occur even after treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897575      PMCID: PMC127107          DOI: 10.1128/AAC.46.4.958-965.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  In-vivo and in-vitro assessment of chloroquine-resistant Plasmodium falciparum malaria in Zanzibar.

Authors:  I K Schwartz; D Payne; C C Campbell; O J Khatib
Journal:  Lancet       Date:  1983-05-07       Impact factor: 79.321

2.  A rhoptry-protein-associated mechanism of clonal phenotypic variation in rodent malaria.

Authors:  P R Preiser; W Jarra; T Capiod; G Snounou
Journal:  Nature       Date:  1999-04-15       Impact factor: 49.962

Review 3.  Epidemiology of drug resistance in malaria.

Authors:  W H Wernsdorfer
Journal:  Acta Trop       Date:  1994-03       Impact factor: 3.112

Review 4.  Overview of clinical studies on artemisinin derivatives in Thailand.

Authors:  S Looareesuwan
Journal:  Trans R Soc Trop Med Hyg       Date:  1994-06       Impact factor: 2.184

5.  In vivo and in vitro sensitivity of Plasmodium falciparum to chloroquine at Lubwe and Kalene in Zambia: use of amodiaquine as an alternative antimalarial drug.

Authors:  M M Lemnge; A W Inambao
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

6.  Mefloquine therapy for Plasmodium falciparum malaria in children under 5 years of age in Malawi: in vivo/in vitro efficacy and correlation of drug concentration with parasitological outcome.

Authors:  L M Slutsker; C O Khoromana; D Payne; C R Allen; J J Wirima; D L Heymann; L Patchen; R W Steketee
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

7.  The antimalarial drug mefloquine binds to membrane phospholipids.

Authors:  R Chevli; C D Fitch
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

8.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

9.  Treatment of patients with recrudescent falciparum malaria with a sequential combination of artesunate and mefloquine.

Authors:  S Looareesuwan; D E Kyle; C Viravan; S Vanijanonta; P Wilairatana; P Charoenlarp; C J Canfield; H K Webster
Journal:  Am J Trop Med Hyg       Date:  1992-12       Impact factor: 2.345

10.  Studies on Plasmodium falciparum in continuous cultivation. I. The effect of chloroquine and pyrimethamine on parasite growth and viability.

Authors:  W H Richards; B K Maples
Journal:  Ann Trop Med Parasitol       Date:  1979-04
View more
  15 in total

1.  Defining the Effectiveness of Antimalarial Chemotherapy: Investigation of the Lag in Parasite Clearance Following Drug Administration.

Authors:  David S Khoury; Deborah Cromer; Jörg J Möhrle; James S McCarthy; Miles P Davenport
Journal:  J Infect Dis       Date:  2016-05-31       Impact factor: 5.226

2.  Phenotypic and genotypic analysis of in vitro-selected artemisinin-resistant progeny of Plasmodium falciparum.

Authors:  Matthew S Tucker; Tina Mutka; Kansas Sparks; Janus Patel; Dennis E Kyle
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

3.  Aminoindoles, a novel scaffold with potent activity against Plasmodium falciparum.

Authors:  Robert H Barker; Sameer Urgaonkar; Ralph Mazitschek; Cassandra Celatka; Renato Skerlj; Joseph F Cortese; Erin Tyndall; Hanlan Liu; Mandy Cromwell; Amar Bir Sidhu; Jose E Guerrero-Bravo; Keila N Crespo-Llado; Adelfa E Serrano; Jing-Wen Lin; Chris J Janse; Shahid M Khan; Manoj Duraisingh; Bradley I Coleman; Inigo Angulo-Barturen; María Belén Jiménez-Díaz; Noemí Magán; Vanesa Gomez; Santiago Ferrer; María Santos Martínez; Sergio Wittlin; Petros Papastogiannidis; Thomas O'Shea; Jeffrey D Klinger; Mark Bree; Edward Lee; Mikaela Levine; Roger C Wiegand; Benito Munoz; Dyann F Wirth; Jon Clardy; Ian Bathurst; Edmund Sybertz
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

4.  Fitness of artemisinin-resistant Plasmodium falciparum in vitro.

Authors:  Amanda Hott; Matthew S Tucker; Debora Casandra; Kansas Sparks; Dennis E Kyle
Journal:  J Antimicrob Chemother       Date:  2015-07-22       Impact factor: 5.790

Review 5.  Malaria biology and disease pathogenesis: insights for new treatments.

Authors:  Louis H Miller; Hans C Ackerman; Xin-zhuan Su; Thomas E Wellems
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

6.  Artemisinin resistance in Plasmodium falciparum: A process linked to dormancy?

Authors:  Qin Cheng; Dennis E Kyle; Michelle L Gatton
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-01-27       Impact factor: 4.077

7.  Antimalarial exposure delays Plasmodium falciparum intra-erythrocytic cycle and drives drug transporter genes expression.

Authors:  Maria Isabel Veiga; Pedro Eduardo Ferreira; Berit Aydin Schmidt; Ulf Ribacke; Anders Björkman; Ales Tichopad; José Pedro Gil
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

Review 8.  Microbial persistence and the road to drug resistance.

Authors:  Nadia R Cohen; Michael A Lobritz; James J Collins
Journal:  Cell Host Microbe       Date:  2013-06-12       Impact factor: 21.023

Review 9.  Protozoan persister-like cells and drug treatment failure.

Authors:  Michael P Barrett; Dennis E Kyle; L David Sibley; Joshua B Radke; Rick L Tarleton
Journal:  Nat Rev Microbiol       Date:  2019-08-23       Impact factor: 60.633

10.  Restructured Mitochondrial-Nuclear Interaction in Plasmodium falciparum Dormancy and Persister Survival after Artemisinin Exposure.

Authors:  Sean V Connelly; Javier Manzella-Lapeira; Zoë C Levine; Joseph Brzostowski; Ludmila Krymskaya; Rifat S Rahman; Angela C Ellis; Shuchi N Amin; Juliana M Sá; Thomas E Wellems
Journal:  mBio       Date:  2021-05-28       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.